新型冠状病毒肺炎防治药物研究进展  

Research progress of the preventive and therapeutic drugs of COVID-19

作　　者：李思远 孙希 LI Si⁃yuan;SUN Xi(Zhongshan School of Medicine,Sun Yat⁃sen University,Guangzhou,Guangdong 510080;Department of Parasitology,Zhongshan School of Medicine,Sun Yat⁃sen University,Guangzhou,Guangdong 510080;Key Laboratory of Tropical Disease Control,Sun Yat⁃sen University,Guangzhou,Guangdong 510080;Ministry of Provincial Engineering Technology Research Center for Biological Vector Control,Guangzhou,Guangdong 510080,China)

机构地区：[1]中山大学中山医学院,广东广州510080 [2]中山大学中山医学院寄生虫学教研室,广东广州510080 [3]中山大学热带病防治教育部重点实验室,广东广州510080 [4]广东省媒介生物防控工程技术中心,广东广州510080

出　　处：《热带医学杂志》2020年第3期286-288,共3页Journal of Tropical Medicine

基　　金：国家重点研发项目(2016YFC1200500);广东省自然科学基金(2019A1515012068);中央高校基本科研业务费专项资金(17kypy09);广州市珠江科技创新人才项目(201710010030)。

摘　　要：2019年12月以来,中国湖北省武汉市出现多起由新型冠状病毒(SARS-CoV-2)引起的肺炎病例,本文从西药和中药两方面分析新型冠状病毒肺炎(COVID-19)防治药物的研究进展--其中西药主要是已有广谱抗病毒药物筛选、老药新用、新型靶向药物的筛选,中药主要是中成药物和方剂的筛选使用等,为有关的研究和对COVID-19的初步认识提供帮助。Corona virus disease 2019(COVID-19)had been reported in Hubei,Wuhan province China since December2019.This article tried to analyze the research progress of the new preventive and therapeutic drugs for COVID-19 from two aspects:Western medicine and traditional Chinese medicine.Western medicine was mainly focusing on screening from the existing broad-spectrum antiviral substances,new drugs used in old drugs and new-targeted drugs.Traditional Chinese medicine was mainly focusing on the selection and the usage of Chinese medicine and prescriptions.This article may provide help for related research and preliminary understanding of COVID-19.

关 键 词：SARS-CoV-2 COVID-19 冠状病毒 防治药物 

分 类 号：R563.1[医药卫生—呼吸系统]